Anondita Medicare Secures Rs 5,16,024 Purchase Order for Condom Supply from Nepal-Based Entity
Anondita Medicare Limited has received purchase orders dated May 27, 2026, from Lotus Pharmaceuticals Private Limited, a Nepal-based entity. The order pertains to the supply of condoms, marking a new international contract for the company.The transaction represents an international sale, with the total consideration valued at Rs 5,16,024/- (Rupees Five Lakhs Sixteen Thousand and Twenty-Four Only).
According to the details provided, the payment terms stipulate a 50% advance payment with the order, with the remaining 50% payable prior to the dispatch and material readiness. The expected delivery timeline for the order is within 4 to 6 weeks from the date the advance payment is received.
The details of the international contract awarded to Anondita Medicare Limited are summarized below:
| Aspect | Detail |
|---|---|
| Customer Entity | Lotus Pharmaceuticals Pvt Ltd |
| Product Nature | Supply of Condoms |
| Transaction Type | International Entity |
| Order Value | Rs 5,16,024/- |
| Payment Terms | 50% advance with order; 50% prior to dispatch and material readiness. |
| Delivery Timeline | Within 4-6 weeks from the date advance receipt. |
| Promoter Interest | None reported |
ANONDITA Stock Price Movement
Anondita Medicare Limited shares settled today, dropping 1.47% to close at ₹1013.25. The stock traded today between a high of ₹1050 and a low of ₹995.05, concluding the session with a total volume of 14,800 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.